Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Signify Health

CVS Is in Advanced Talks to Buy Signify Health

CVS Health Corp.  CVS, -0.49% is in advanced talks to acquire home-healthcare company Signify Health Inc. SGFY, +1.34% for around $8 billion, according to people familiar with the matter.

CVS said to be closing in deal to acquire home-health company Signify

CVS Health Corp is in advanced talks to acquire home-healthcare company Signify Health Inc for around $8 billion, the Wall Street Journal reported on Friday, citing people familiar with the matter.

CVS in advanced talks to buy Signify Health for $8 billion - WSJ

Deal could be made final soon, sources say.

CVS in Advanced Talks to Buy Signify Health

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Why Is CVS Health (CVS) Down 1.9% Since Last Earnings Report?

This commentary first appeared on  Forbes Great Speculations , where Schaeffer's Investment Research is a regular contributor.

Bull Signal Could Push CVS Health Stock Towards 2022 Highs

AbbVie

Abbott Labs

Buying these stocks now could lead to dividend payments that grow for the rest of your life.

3 Dividend Stocks to Buy in September for Passive Income Generation

Amazon

CrowdStrike

Occidental Petroleum

PayPal

Shopify

Upstart Holdings

Billionaire money managers have used the sizable market downturn to buy these seven stocks at a perceived discount.

Billionaires Have Been Buying These 7 Stocks as the Market Plunges

WOONSOCKET, R.I. , Aug. 31, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S.

CVS Health to Present at the 20th Annual Morgan Stanley Global Healthcare Conference

CVS Health's products and services are essential, which shields it from a recession more than most other businesses.

Looking for Recession-Proof Passive Income? Buy This Stock

Amgen

Bristol-Myers

Gilead Sciences

Eli Lilly

Merck

Pfizer

The stock market rally ran into the harsh reality last Friday that any interest rate pivot by the Federal Reserve may not come until 2024.

8 Safe ‘Strong Buy' Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

Ally Financial

Constellation Energy Corp

Find out why legendary investors were recently eager to buy these stocks.

3 Dividend-Paying Stocks Billionaires Are Buying Hand Over Fist

Elevance Health Inc

Raytheon Technologies

TE Connectivity PLC

UnitedHealth Group

The second quarter of 2022 saw the U.S. Federal Reserve continue hiking interest rates as inflation remained sky-high. Unless companies can raise their profits more than 9% year over year to surpass inflation, they are effectively seeing their profits decrease on an inflation-adjusted basis, which is not exactly a recipe for a bull market.

The Most-Sold Guru Stocks of the 2nd Quarter

Netflix

Ray Dalio may not get as much attention as some other hedge fund managers like Cathie Wood, Jim Simons and Steven Cohen. Yet, he's earned his place among the world's top fund managers.

3 Stocks That Ray Dalio Is Betting On Now

CVS Health (CVS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CVS Health (CVS) Moves to Buy: Rationale Behind the Upgrade

Share of Signify jumped 40% on reports that a bidding war could value the firm at more than $8 billion.

Signify Health Stock Surges As Amazon Reportedly Joins Potential Bidding War With CVS, UnitedHealth

Several major companies are bidding to buy Signify Health. The bidders reportedly include UnitedHealth, Amazon, CVS Health and Option Care Health.

UnitedHealth, Amazon, CVS Health, Option Care bidding on Signify Health

Amazon.com Inc (NASDAQ:AMZN), CVS Health Corp, Option Care Health Inc, and UnitedHealth Group Inc are all understood to be bidding for Signify Health Inc, according to weekend news reports cited by Reuters. UnitedHealth has submitted the highest bid in excess of $30 a share, while Amazon's offer is close behind, Reuters said.

Amazon.com, CVS Health, Option Care Health, and UnitedHealth all understood to be bidding for Signify Health - reports

Walgreens and CVS look to be on another collision course.

CVS Is Planning a Big Move This Year

Walgreens

Walmart

Walmart, CVS, and Walgreens must pay a combined $650.6 million to two Ohio counties for damages related to the opioid crisis, a federal judge ruled Wednesday.

Ohio judge rules Walmart, CVS, and Walgreens must pay a combined $650.6 million for damages related to opioid crisis

CLEVELAND — A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.

CVS, Walmart, Walgreens owe two Ohio counties $650 million in landmark opioid lawsuit

CVS, Walgreens and Walmart must pay damages to two Ohio counties for oversupplying pills that ended up on black market

US pharmacies ordered to pay $650.6m for role in opioids crisis

43 percent of Americans say they'll visit a retail pharmacy to get the flu vaccine this season CVS.com and the CVS Pharmacy app allow families to schedule multiple appointments at once, providing added convenience WOONSOCKET, R.I. , Aug. 16, 2022 /PRNewswire/ -- CVS Health® (NYSE: CVS) is reminding Americans that it is more important than ever to stay current with vaccinations and other routine health care needs.

Flu shots now available at CVS Pharmacy® and MinuteClinic® nationwide

CVS Health stock (NYSE: CVS) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.

What's Next For CVS Health Stock After An Upbeat Q2?

A lot will come down to how much you invest in the business, and what kind of return you should expect from the stock.

News for CVS Health Stock (CVS)